For over 60 years Novartis has been committed to helping people with cardiovascular disease and we remain steadfast in that commitment to this day.

Novartis researchers have discovered a compound that is showing promise against three parasites that cause three neglected diseases.

Florencia Segal’s experiences prepared her to lead the rapid design of a large COVID-19 clinical trial.

Novartis researchers are partnering with advocacy groups to understand the stigma and challenges facing patients with obesity.

An investigational treatment for an uncommon immunodeficiency disease races into clinical studies.

Researchers focus on reversing the scarring that’s common to liver diseases.

Researchers from Seattle Children’s and Novartis shed light on developmental brain disorders that lead to intractable epilepsy.

A certain leggy resident of the African grasslands is arousing a lot of interest among evolutionary biologists. They believe that study of giraffes' unique features could lead the way to advances in human health.